Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $621.63 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $174.40 | 11 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $120.98 | 10 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $97.83 | 4 | $0 (2022) |
| Adamas Pharmaceuticals, Inc. | $74.79 | 5 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $53.50 | 3 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $49.22 | 3 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $35.73 | 2 | $0 (2022) |
| Novo Nordisk Inc | $15.18 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $154.80 | 9 | Sunovion Pharmaceuticals Inc. ($54.52) |
| 2021 | $451.65 | 29 | Amneal Pharmaceuticals LLC ($158.98) |
| 2019 | $15.18 | 1 | Novo Nordisk Inc ($15.18) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/22/2022 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CNS | ||||||
| 02/16/2022 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| 02/15/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROLOGY | ||||||
| 01/25/2022 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: CNS | ||||||
| 01/19/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Neuropsychiatry | ||||||
| 01/18/2022 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| 01/11/2022 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: CNS | ||||||
| 01/05/2022 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: CNS | ||||||
| 12/14/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/08/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: CNS | ||||||
| 11/17/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: PD | ||||||
| 11/10/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: CNS | ||||||
| 11/03/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: CNS | ||||||
| 10/26/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/20/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: CNS | ||||||
| 10/13/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/12/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROLOGY | ||||||
| 10/06/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: CNS | ||||||
| 09/21/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROLOGY | ||||||
| 09/15/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: CNS | ||||||
| 09/14/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: NEUROLOGY | ||||||
| 08/17/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 64 | 85 | $20,359 | $8,921 |
| 2021 | 2 | 89 | 111 | $23,773 | $11,061 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 43 | 61 | $16,034 | $7,220 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 24 | $4,325 | $1,701 | 39.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 51 | 54 | $13,684 | $6,238 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 38 | 57 | $10,089 | $4,823 | 47.8% |
About Dr. Nora Lee, MD
Dr. Nora Lee, MD is a Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063536894.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nora Lee, MD has received a total of $621.63 in payments from pharmaceutical and medical device companies, with $154.80 received in 2022. These payments were reported across 39 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($621.63).
As a Medicare-enrolled provider, Lee has provided services to 153 Medicare beneficiaries, totaling 196 services with total Medicare billing of $19,982. Data is available for 2 years (2021–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Hartford, CT
- Active Since 03/19/2007
- Last Updated 02/29/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063536894
Products in Payments
- RYTARY (Drug) $174.40
- KYNMOBI (Drug) $120.98
- GOCOVRI (Drug) $74.79
- INGREZZA (Drug) $70.50
- NUPLAZID (Drug) $49.22
- Nuedexta (Drug) $36.54
- ONGENTYS (Drug) $27.33
- NUEDEXTA (Drug) $16.96
- Ozempic (Drug) $15.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hartford
Dr. Tapan Mehta, M.b.b.s, M.B.B.S
Neurology — Payments: $31,259
Dr. Lawrence Bluth, M.d, M.D
Neurology — Payments: $14,628
Dr. Stephen Conway, M.d, M.D
Neurology — Payments: $11,972
Dr. Brian Wong, M.d, M.D
Neurology — Payments: $8,026
Keshav Rao, Md, MD
Neurology — Payments: $3,525
Alexis Demopoulos, Md, MD
Neurology — Payments: $3,008